Diltiazem: Difference between revisions
(Switch SMW query from broadtable to table format for better layout with TOC) |
|||
| (8 intermediate revisions by 4 users not shown) | |||
| Line 7: | Line 7: | ||
*Common Trade Names: Cardizem | *Common Trade Names: Cardizem | ||
== | ==Adult Dosing== | ||
===[[Atrial fibrillation with rapid ventricular response]] (if hemodynamically stable)=== | |||
* | *Loading dose = 0.25 mg/kg (max=20 mg) IV bolus over 2 minutes | ||
**Can consider breaking down into 10 mg boluses in older patients to decrease risk of adverse reactions | |||
**If ineffective after 15 minutes: 0.35mg/kg (max=25mg) over 2 minutes | |||
**If effective: Start infusion at 5-15 mg/hr | |||
***Consider 30mg IR PO or home dose to avoid need for a drip | |||
== | ===[[Supraventricular tachycardia]] (if hemodynamically stable)=== | ||
*Same as for atrial fibrillation with rapid ventricular response (see above) | |||
* | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
| Line 21: | Line 23: | ||
==Special Populations== | ==Special Populations== | ||
===[[Drug pregnancy categories|Pregnancy Rating]]=== | |||
* Pregnancy Rating: C | * Pregnancy Rating: C | ||
* Lactation: | |||
===Lactation risk=== | |||
* Hepatic Dosing: Not studied, use caution | * Lactation: Does appear to diffuse into breast milk, but doses are typically not harmful to infants | ||
===Renal Dosing=== | |||
*Adult: Not studied, use caution | |||
*Pediatric: Not studied, use caution | |||
===Hepatic Dosing=== | |||
*Adult: Not studied, use caution | |||
*Pediatric: Not studied, use caution | |||
==Contraindications== | ==Contraindications== | ||
*Allergy to drug/class | *[[Allergy]] to drug/class | ||
*Infants <1yo | *Infants <1yo | ||
*Wide-complex tachycardia due to bypass tract (e.g. WPW) | *[[Wide-complex tachycardia]] due to bypass tract (e.g. WPW) | ||
*Symptomatic severe hypotension | *Symptomatic severe hypotension | ||
*Sick sinus syndrome/2nd or 3rd degree heart block if no pacemaker | *[[Sick sinus syndrome]]/2nd or 3rd degree heart block if no pacemaker | ||
*PO: acute MI and pulmonary congestion | *PO: acute [[MI]] and pulmonary congestion | ||
*Ventricular tachycardia | *[[Ventricular tachycardia]] | ||
*Caution if: | *Caution if: | ||
**Hypertrophic cardiomyopathy | **Hypertrophic cardiomyopathy | ||
| Line 71: | Line 82: | ||
*Class IV - Inhibits Ca influx | *Class IV - Inhibits Ca influx | ||
**Slows AV nodal conduction | **Slows AV nodal conduction | ||
==Comments== | |||
==Indications by Condition== | |||
''The following table is automatically generated from disease/condition pages across WikEM.'' | |||
{{#ask:[[Has DrugName::Diltiazem]] | |||
|?Has Indication=Indication | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|?Has Route=Route | |||
|?Has Population=Population | |||
|format=table | |||
|headers=plain | |||
|mainlabel=- | |||
|sort=Has Indication | |||
|limit=50 | |||
}} | |||
==See Also== | ==See Also== | ||
| Line 76: | Line 106: | ||
*[[Calcium Channel Blocker Toxicity]] | *[[Calcium Channel Blocker Toxicity]] | ||
*[[Atrial Fibrillation with RVR]] | *[[Atrial Fibrillation with RVR]] | ||
==References== | |||
<references/> | |||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Latest revision as of 21:55, 20 March 2026
Administration
- Type: Calcium channel blocker
- Dosage Forms
- IV: 25 mg/5 mL and 50 mg/10 mL bottles
- Oral: 30 mg, 60 mg, 90 mg
- Routes of Administration: IV, PO
- Common Trade Names: Cardizem
Adult Dosing
Atrial fibrillation with rapid ventricular response (if hemodynamically stable)
- Loading dose = 0.25 mg/kg (max=20 mg) IV bolus over 2 minutes
- Can consider breaking down into 10 mg boluses in older patients to decrease risk of adverse reactions
- If ineffective after 15 minutes: 0.35mg/kg (max=25mg) over 2 minutes
- If effective: Start infusion at 5-15 mg/hr
- Consider 30mg IR PO or home dose to avoid need for a drip
Supraventricular tachycardia (if hemodynamically stable)
- Same as for atrial fibrillation with rapid ventricular response (see above)
Pediatric Dosing
- Contraindicated in pediatric patients <1yo
- See critical care quick reference for drug doses by weight
Special Populations
Pregnancy Rating
- Pregnancy Rating: C
Lactation risk
- Lactation: Does appear to diffuse into breast milk, but doses are typically not harmful to infants
Renal Dosing
- Adult: Not studied, use caution
- Pediatric: Not studied, use caution
Hepatic Dosing
- Adult: Not studied, use caution
- Pediatric: Not studied, use caution
Contraindications
- Allergy to drug/class
- Infants <1yo
- Wide-complex tachycardia due to bypass tract (e.g. WPW)
- Symptomatic severe hypotension
- Sick sinus syndrome/2nd or 3rd degree heart block if no pacemaker
- PO: acute MI and pulmonary congestion
- Ventricular tachycardia
- Caution if:
- Hypertrophic cardiomyopathy
- LV dysfunction
- Concomitant beta-blockade
- Hepatic/renal impairment
- Heart failure
Adverse Reactions
Serious
Common
- Peripheral edema
- Elevated LFTs
- Headache
- Dizziness
- Nausea/vomiting, diarrhea, contipation
- Flushing, vasodilation
- Gingival hyperplagia
- Myalgia
- Bronchitis, sinus congestion, dypsnea
- Hemolytic anemia, thrombocytopenia
- Extrapyramidal symptoms
Pharmacology
- Onset of action = 2-3min (IV)
- Duration of action = 1-3hr (IV)
- Half life: 3-5h
- Metabolism: Hepatic
- Excretion: Urine/feces
Mechanism of Action
- Class IV - Inhibits Ca influx
- Slows AV nodal conduction
Comments
Indications by Condition
The following table is automatically generated from disease/condition pages across WikEM.
| Indication | Dose | Context | Route | Population |
|---|---|---|---|---|
| Atrial fibrillation (main) | 0.25-0.35 mg/kg IV (typical 20 mg), then 25 mg IV if needed; followed by 60-120 mg PO or drip | Rate control (1st line CCB) | IV/PO | Adult |
| Atrial fibrillation with RVR | 0.25mg/kg (max 20mg) IV over 2min; repeat 0.35mg/kg after 15min; drip 5-20mg/hr | First-line rate control (CCB) | IV | Adult |
| Atrial flutter | 2.5 mg/min until HR <100 (max 50 mg) | Rate control | IV | Adult |
| Nontraumatic thoracic aortic dissection | 0.25mg/kg load over 2-5min, then 5mg/hr infusion | Heart rate control if beta-blocker contraindicated | IV | Adult |
| Paroxysmal supraventricular tachycardia | 0.25 mg/kg IV over 2 min; may repeat 0.35 mg/kg after 15 min; then infusion 5-20 mg/hr | Calcium-channel blocker (2nd line) | IV/IV drip | Adult |
